Evidence map›Paper›PMID 26957765›Full record

ArticleJournal of physical therapy science2016

Usefulness of ceruloplasmin testing as a screening methodology for geriatric patients with osteoporosis.

Emel Yigit Karakas, Alpaslan Yetisgin, Dursun Cadirci, Hatice Sezen, Rıza Altunbas, Fehmi Kas, Mehmet Demir, Turgay Ulas

Abstract read
In one paragraph

Article in Journal of physical therapy science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emel Yigit KarakasDepartment of Internal Medicine, Faculty of Medicine, Harran University, Turkey.
Alpaslan YetisginDepartment of Physical Therapy and Rehabilitation, Harran University School of Medicine, Turkey.
Dursun CadirciDepartment of Family Physician, Faculty of Medicine, Harran University, Turkey.
Hatice SezenDepartment of Biochemistry, Harran University School of Medicine, Turkey.
Rıza AltunbasDepartment of Internal Medicine, Faculty of Medicine, Harran University, Turkey.
Fehmi KasDepartment of Internal Medicine, Faculty of Medicine, Harran University, Turkey.
Mehmet DemirDepartment of Internal Medicine, Faculty of Medicine, Harran University, Turkey.
Turgay UlasDepartment of Internal Medicine, Faculty of Medicine, Harran University, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Purpose] To evaluate serum ceruloplasmin levels in geriatric patients with osteoporosis. [Subjects and Methods] Seventy geriatric patients over 65 years of age were recruited. Patients were divided into two groups: group 1 ('OP', n=35) consisted of patients with osteoporosis, and group 2 (n=35) consisted of patients without osteoporosis. Dual-energy X-ray absorptiometry scanning was used in the measurement of bone mineral density in all cases. Inflammatory parameters, including C-reactive protein, sedimentation rate, and serum ceruloplasmin levels were analyzed in blood samples. [Results] No statistical differences in inflammatory parameters were observed between the two groups, however, serum ceruloplasmin levels were significantly higher in group 1 than in group 2. In Pearson analysis, serum ceruloplasmin levels were not found to be correlated with any biochemical parameters. Receiver operator characteristic curve analysis revealed that serum ceruloplasmin levels were predictive of osteoporosis with 85.7% sensitivity and 85.7% specificity over the level of 830.15. [Conclusion] Our study demonstrated that measurement of serum ceruloplasmin levels may have potential as a screening methodology for geriatric patients with osteoporosis.

Indexed as

CeruloplasminOsteoporosisScreening test

Identifiers

PMID26957765
PMCPMC4756011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.